Kairos Pharma Files 8-K
Ticker: KAPA · Form: 8-K · Filed: Apr 24, 2025 · CIK: 1962011
| Field | Detail |
|---|---|
| Company | Kairos Pharma, LTD. (KAPA) |
| Form Type | 8-K |
| Filed Date | Apr 24, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, 8-k
TL;DR
Kairos Pharma filed an 8-K, but no juicy details yet.
AI Summary
On April 24, 2025, Kairos Pharma, Ltd. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits," with no specific material events or financial details disclosed in the provided text. The company is incorporated in Delaware and its principal executive offices are located in Los Angeles, California.
Why It Matters
This 8-K filing indicates Kairos Pharma, Ltd. has submitted a regulatory report, but the provided excerpt does not contain details of specific events or financial performance.
Risk Assessment
Risk Level: low — The filing is a routine 8-K submission without disclosure of any new material events or financial information that would indicate increased risk.
Key Players & Entities
- Kairos Pharma, Ltd. (company) — Registrant
- April 24, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 2355 Westwood Blvd. , #139 Los Angeles CA 90064 (address) — Address of principal executive offices
FAQ
What specific events are reported in this 8-K filing by Kairos Pharma, Ltd.?
The provided text indicates the filing concerns 'Other Events' and 'Financial Statements and Exhibits,' but does not specify the details of these events.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on April 24, 2025.
What is the principal executive office address for Kairos Pharma, Ltd.?
The principal executive office address for Kairos Pharma, Ltd. is 2355 Westwood Blvd. , #139 Los Angeles CA 90064.
In which state is Kairos Pharma, Ltd. incorporated?
Kairos Pharma, Ltd. is incorporated in Delaware.
What is the telephone number for Kairos Pharma, Ltd.?
The telephone number for Kairos Pharma, Ltd. is (310) 948-2356.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 24, 2025 regarding Kairos Pharma, LTD. (KAPA).